Sedative doses of propofol increase beta activity of the processed electroencephalogram

Delirium screening in the intensive care unit using emerging QEEG techniques: A pilot study

Delirium is an under-diagnosed yet frequently occurring clinical complication with potentially serious consequences for intensive care unit (ICU) patients. Diagnosis is currently reactive and based upon qualitative assessment of the patient's cognitive status by ICU staff. Here, we conducted a preliminary investigation into whether emerging quantitative electroencephalography (QEEG) analysis techniques can accurately discriminate between delirious and non-delirious patients in an ICU setting. Resting EEG recordings from 5 ICU patients in a state of delirium and 5 age matched control patients were analyzed using autoregressive spectral estimation for quantification of EEG power and renormalized partial directed coherence for analysis of directed functional connectivity. Delirious subjects exhibited pronounced EEG slowing as well as severe general loss of directed functional connectivity between recording sites. Distinction between groups based on these parameters was surprisingly clear given the low sample size employed. Furthermore, by targeting the electrode positions where effects were most apparent it was possible to clearly segregate patients using only 3 scalp electrodes. These findings indicate that quantitative diagnosis and monitoring of delirium is not only possible using emerging QEEG methods but is also accomplishable using very low-density electrode systems.

The Narcotrend monitor and the electroencephalogram in propofol-induced sedation

BACKGROUND

The Narcotrend (NCT) is a one-channel electroencephalogram (EEG) monitor of the level of sedation. It is based on a visual EEG scoring system, which was developed by Loomis and modified by Kugler, to yield a visual expert classification (VEC) scheme for differentiation of six levels of sedation (A-F), which are subdivided into 16 substages. We designed the present study to test whether results of the automated classification of one-channel NCT input reflect those from VEC of five-channel EEG.

METHODS

Twelve healthy male volunteers received propofol using two different infusion regimens in a randomized, crossover design with concomitant NCT monitoring and VEC. Scoring results of NCT were compared with those of VEC.

RESULTS

During the infusion period, score differences of more than three substages were observed in 14 of 24 (= 58%) propofol administrations (4%-7% of total data). Often, the NCT indicated lighter sedation than VEC, which revealed more delta activity from nonfrontal leads. During recovery, NCT reported deeper sedation than VEC in 6 of 24 (= 25%) propofol administrations. Discordant trends (periods of at least five subsequent epochs with monotonic, but opposite trends for both NCT and VEC) were noted in 9 of 24 propofol administrations (37%). Furthermore, NCT had several periods when no staging information was displayed, varying from a few seconds to 10 min.

CONCLUSIONS

As the algorithm of NCT is proprietary and not accessible to the public, reasons for the observed differences between NCT and VEC cannot be analyzed and explanations must remain speculative.

Relation of EEG spectrum progression to loss of responsiveness during induction of anesthesia with propofol

OBJECTIVE

Our purpose is to find out whether the Loss of obeying a Verbal Command (LVC) and the preceding progression of the EEG frequency patterns are mutually related during an anesthetic induction.

METHODS

EEG was analyzed from sixteen patients, anesthetized with a fixed rate infusion of propofol (30 mg/kg/h). An artifact-purified EEG from electrode Fz referenced to the average of mastoid signals was filtered to consecutive 4 Hz frequency passbands with a filter bank. Signal envelope time-series were computed for all the passbands and studied as a function of the elapsed induction time t and as a function of the relative time r, which is t divided by the time of the LVC.

RESULTS

A frequency band specific biphasic activity pattern progressed from high towards low frequencies systematically and uniformly in the population studied when presented on the relative time scale r, irrespective of individual responses to the dosage.

CONCLUSIONS

The grouping of the individual progression patterns on the r scale indicates a strong relation between the EEG spectral behavior and the LVC.

SIGNIFICANCE

EEG may provide phenomenological grounds for a continuous control variable of a sedative drug effect, even in between the discrete clinical end-points.

The effect of interruption to propofol sedation on auditory event-related potentials and electroencephalogram in intensive care patients

Introduction

In this observational pilot study we evaluated the electroencephalogram (EEG) and auditory event-related potentials (ERPs) before and after discontinuation of propofol sedation in neurologically intact intensive care patients.

Methods

Nineteen intensive care unit patients received a propofol infusion in accordance with a sedation protocol. The EEG signal and the ERPs were measured at the frontal region (Fz) and central region (Cz), both during propofol sedation and after cessation of infusion when the sedative effects had subsided. The EEG signal was subjected to power spectral estimation, and the total root mean squared power and spectral edge frequency 95% were computed. For ERPs, we used an oddball paradigm to obtain the N100 and the mismatch negativity components.

Results

Despite considerable individual variability, the root mean squared power at Cz and Fz (P = 0.004 and P = 0.005, respectively) and the amplitude of the N100 component in response to the standard stimulus at Fz (P = 0.022) increased significantly after interruption to sedation. The amplitude of the N100 component (at Cz and Fz) was the only parameter that differed between sedation levels during propofol sedation (deep versus moderate versus light sedation: P = 0.016 and P = 0.008 for Cz and Fz, respectively). None of the computed parameters correlated with duration of propofol infusion.

Conclusion

Our findings suggest that use of ERPs, especially the N100 potential, may help to differentiate between levels of sedation. Thus, they may represent a useful complement to clinical sedation scales in the monitoring of sedation status over time in a heterogeneous group of neurologically intact intensive care patients.

[Which propofol target concentration for ASA III elderly patients for conscious sedation combined with regional anaesthesia?]

OBJECTIVE

To determine the optimal propofol target concentration between 0.9-1.1 and 1.3 mg l(-1), for conscious sedation and amnesia using Diprifusor in ASA III patients over 60 years.

STUDY DESIGN

Prospective study.

PATIENTS AND METHODS

In ASA III patients over 60 years presented for elective vascular procedures under regional anaesthesia, sedation was induced with propofol TCI by increasing target concentrations from 0.9 to 1.3 mg l(-1) by 0.2 mg l(-1) steps up to a sedation score corresponding to light level (patient awakable with tactile stimulation). At baseline and each step, specific pictures were shown to the patient and clinical parameters and unwanted side effects occurrence were recorded. In PACU, memorisation of pictures and events was looked for.

RESULTS

Conscious sedation was obtained in 100% of the patients at 0.9 mg l(-1), 94% at 1.1 and 78% at 1.3 mg l(-1). Amnesia was concentration-dependent and for each concentration was always more important for pictures than for events. Haemodynamic parameters did not change significantly. Incidents occurred in 12% of cases at 1.1 and 39.4% at 1.3 mg l(-1).

DISCUSSION

None of those three concentrations was satisfying in 100% of cases for the three criterias (sedation < S2, amnesia and none side effects). These results suggest that propofol target concentration 0.9 microg ml(-1) could be used safely for sedation in elderly ASA III patients. Moreover, we have shown that amnesia for events requires higher propofol concentrations than amnesia for pictures during conscious sedation.

Progressive electroencephalogram frequency deceleration despite constant depth of propofol-induced sedation

OBJECTIVE

To investigate a possible time-dependent effect of propofol sedation on electroencephalographic activity, we analyzed the electroencephalogram frequency behavior while keeping patients at a constant level of sedation.

DESIGN

Prospective, controlled trial.

SETTING

Intensive care unit of a university hospital.

PATIENTS

Twenty patients without neurologic or metabolic disorders.

MEASUREMENTS AND MAIN RESULTS

During sedation with propofol (1-4 mg x kg(-1) x hr(-1)), a bifrontally recorded processed electroencephalogram was obtained. For 48 hrs, sedation was kept constant at a level according to Ramsay Scale 3 while we adjusted the dosage of propofol given per hour. At hours 6, 18, 30, and 42, blood samples were taken to assess the plasma concentration of propofol. The electroencephalogram values of 60 mins obtained during 1 hr before blood sampling were taken for further calculation. From the data, relative band power of the beta-, alpha-, theta, and delta-bands, spectral median frequency, and spectral edge frequency 90 and 95 were computed. For statistical analysis, a polynomial three-factorial repeated-measures analysis of variance with covariates was performed. Relative power of beta- and alpha-wavebands showed a constant and significant decrease over time (beta, 15.5%, 10.3%, 10.3%, 7.6%; alpha, 14.8%, 13.4%, 10.0%, 8.3%), whereas relative delta power increased (delta, 56.4%, 63.4%, 70.7%, 72.3%). The theta-waveband remained unchanged. Accordingly, spectral edge frequency 90 and 95 and spectral median frequency decreased significantly. From hours 6 to 18, a significant increase of the plasma propofol concentration was found. Subsequently, the level remained constant.

CONCLUSION

Despite constant sedation, a longer period of propofol application induces a time-dependent electroencephalogram frequency deceleration. The use of electroencephalogram derivatives to monitor depth of sedation in the intensive care unit thus should be regarded cautiously.

Autonomic circulatory and cerebrocortical responses during increasing depth of propofol sedation/hypnosis in humans

PURPOSE

To describe the relative effects of graded central nervous system (CNS) depression, using increasing propofol infusion rates, on neurovegetative brainstem-mediated circulatory control mechanisms and higher cortical activity in healthy humans.

METHODS

Propofol was administered using an infusion scheme designed to achieve three target blood concentrations in ten healthy volunteers. Blood propofol concentrations and sedation scores were determined at baseline, during the three propofol infusion levels, and 30 min into the recovery period. Electroencephalographic (EEG) power was measured in three frequency bands to quantify cortical activity, and autonomic heart rate control was quantified using spontaneous baroreflex assessment and power spectral analysis of pulse interval.

RESULTS

Sedation scores closely paralleled propofol blood concentrations (0, 0.53 +/- 0.34, 1.24 +/- 0.21, 3.11 +/- 0.80, and 0.96 +/- 0.42 microg x mL(-1) at baseline, three infusion levels and recovery respectively), and all subjects were unconscious at the deepest level. Indices of autonomic heart rate control were decreased only at the deepest levels of CNS depression, while EEG effects were apparent at all propofol infusion rates. These EEG effects were frequency specific, with power in the beta band being affected at light levels of sedation, and alpha and delta power altered at deeper levels.

CONCLUSIONS

The results of this study support a relative preservation of neurovegetative circulatory control mechanisms during the early stages of CNS depression using gradually increasing rates of infusion of propofol. Indices of circulatory control did not reliably reflect depth of sedation.

Propofol sedation during awake craniotomy for seizures: electrocorticographic and epileptogenic effects

This prospective study evaluated the effects of propofol sedation on the incidence of intraoperative seizures and the adequacy of electrocorticographic (ECoG) recordings during awake craniotomy performed for the management of refractory epilepsy. Thirty patients scheduled for temporal or frontal lobectomy for epilepsy under bupivacaine scalp block were randomized to receive patient-controlled propofol sedation (PCS) combined with a basal infusion of propofol (n = 15) or neurolept analgesia using an initial bolus dose of fentanyl (0.7 microg/kg) and droperidol (0.04 mg/kg) followed by a fentanyl infusion (n = 15). Propofol administration was suspended 15 min before ECoG recording in the PCS group. The occurrence of inappropriate intraoperative seizures was noted and, based on blind review, the adequacy of ECoG recordings was compared. A higher incidence of intraoperative seizures was noted among the neurolept patients (6 vs 0, P = 0.008). Intraoperatively, ECoG recordings were adequate to proceed with resection in both groups. Evidence of low spike activity on ECoG did not correlate with the type of sedation administered. Higher frequency background ECoG activity was noted among patients who received propofol, but this did not interfere with ECoG interpretation. The use of propofol sedation does not appear to interfere with ECoG during epilepsy surgery, provided administration is suspended at least 15 min before recording.

Topographic electroencephalogram of propofol-induced conscious sedation

OBJECTIVES

To determine the effects of increasing doses of propofol that induce conscious sedation on the topographic electroencephalogram (EEG) of human volunteers and to test the hypothesis that more frontal brain areas are affected by low doses of propofol.

METHODS

The scalp EEG was recorded monopolarly from 16 different sites based on the 10-20 International System. Microcomputer-based hardware and RHYTHM 7.1 software were used to obtain quantitative power frequency topographic EEG data. A total of 10 normal adult volunteers were given incremental doses of propofol targeted to plasma concentrations of 0 to 1200 ng/ml.

RESULTS

Sedative concentrations of propofol produced a dramatic increase in beta 1, an increase in alpha 2 and beta 2, and an increase in delta activity at the largest concentration, with almost no change in theta activity. The increase in beta 1 activity had a linear correlation with plasma propofol levels (r = 0.9). Topographic mapping indicated that beta 1 activation was primarily in the frontal and central regions, with focal changes more in the left hemisphere.

CONCLUSIONS

Topographic brain EEG mapping techniques indicate that frontal brain beta 1 EEG activity may be useful as an objective brain index of propofol conscious sedation.

Propofol blood concentration and the Bispectral Index predict suppression of learning during propofol/epidural anesthesia in volunteers

Propofol is often used for sedation during regional anesthesia. We tested the hypothesis that propofol blood concentration, the Bispectral Index and the 95% spectral edge frequency predict suppression of learning during propofol/epidural anesthesia in volunteers. In addition, we tested the hypothesis that the Bispectral Index is linearly related to propofol blood concentration. Fourteen healthy, male volunteers were studied on three randomly ordered days: no propofol, target propofol blood concentration 1 microgram/mL, and target propofol blood concentration 2 micrograms/mL. Each day, epidural anesthesia (approximately T11 level) was induced using 2% 2-chloroprocaine. Propofol was infused by a computer-controlled pump, and propofol concentration measured in central venous blood. We administered a Trivial Pursuit-type question task on all 3 days. The electroencephalogram was monitored continuously (Fp1, Fp2; reference, Cz; ground, mastoid). Propofol caused concentration-related impairment of learning. The propofol blood concentration suppressing learning by 50% was 0.66 +/- 0.1 microgram/mL. The Bispectral Index value when learning was suppressed by 50% was 91 +/- 1. In contrast, the 95% spectral edge frequency did not correlate well with learning. The Bispectral Index decreased linearly as propofol blood concentration increased (Bispectral Index = -7.4.[propofol] + 90; r2 = 0.47, n = 278). There was no significant correlation between the 95% spectral edge frequency and propofol concentration. In order to suppress learning, propofol blood concentrations reported to produce amnesia may be targeted. Alternatively, the Bispectral Index may be used to predict anesthetic effect during propofol sedation.

Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation

Propofol is a phenolic derivative that is structurally unrelated to other sedative hypnotic agents. It has been used extensively as an anaesthetic agent, particularly in procedures of short duration. More recently it has been investigated as a sedative in the intensive care unit (ICU) where it produces sedation and hypnosis in a dose-dependent manner. Propofol also provides control of stress responses and has anticonvulsant and amnesic properties. Importantly, its pharmacokinetic properties are characterised by a rapid onset and short duration of action. Noncomparative and comparative trials have evaluated the use of propofol for the sedation of mechanically ventilated patients in the ICU (postsurgical, general medical, trauma). Overall, propofol provides satisfactory sedation and is associated with good haemodynamic stability. It produces results similar to or better than those seen with midazolam or other comparator agents when the quality of sedation and/or the amount of time that patients were at adequate levels of sedation are measured. Patients sedated with propofol also tend to have a faster recovery (time to spontaneous ventilation or extubation) than patients sedated with midazolam. Although most studies did not measure time to discharge from the ICU, propofol tended to be superior to midazolam in this respect. In a few small trials in patients with head trauma or following neurosurgery, propofol was associated with adequate sedation and control of cerebral haemodynamics. The rapid recovery of patients after stopping propofol makes it an attractive option in the ICU, particularly for patients requiring only short term sedation. In short term sedation, propofol, despite its generally higher acquisition costs, has the potential to reduce overall medical costs if patients are able to be extubated and discharged from the ICU sooner. Because of the potential for hyperlipidaemia and the development of tolerance to its sedative effects, and because of the reduced need for rapid reversal of drug effects in long term sedation, the usefulness of propofol in long term situations is less well established. While experience with propofol for the sedation of patients in the ICU is extensive, there are still areas requiring further investigation. These include studies in children, trials examining cerebral and haemodynamic outcomes following long term administration and in patients with head trauma and, importantly, pharmacoeconomic investigations to determine those situations where propofol is cost effective. In the meantime, propofol is a well established treatment native to benzodiazepines and/or other hypnotics or analgesics when sedation of patients in the ICU is required. In particular, propofol possesses unique advantages over these agents in patients requiring only short term sedation.

Cognitive and EEG recovery following bolus intravenous administration of anesthetic agents

Bolus intravenous (IV) administration of commonly used IV anesthetic agents such as fentanyl and the fentanyl analogues, alfentanil, remifentanil, and sufentanil, etomidate and propofol, produced anesthesia in rats as measured by the loss of righting (LOR) with calculated ED150 doses of 0.06, 0.09, 0.037, 0.007, 2.51 and 6.12 mg/kg, respectively. Animals trained in an eight arm radial maze (RAM) were assessed for cognitive recovery, as measured by response efficiency (percentage of correct arm entries within 10 min), immediately, 15 min and 30 min following IV administration of the calculated ED150 dose of each of these agents, and the subsequent return of righting (ROR). Animals administered fentanyl or sufentanil were unable to successfully complete the maze throughout the testing periods. Animals receiving remifentanil showed cognitive recovery within the first testing interval (immediately following the return of righting), while animals receiving alfentanil, etomidate or propofol showed recovery at the 15-min testing interval following ROR. In a separate experiment, bolus IV administration of the ED150 dose of these agents was evaluated in an acute rat EEG model. Following ROR, return to baseline EEG levels occurred at 0.30, 2.88, 5.06, 16.25, 31.29 and 43.98 min for remifentanil, propofol, alfentanil, etomidate, fentanyl and sufentanil, respectively. These data show that the return to efficient cognitive functioning corresponds to the return to normal baseline EEG waveforms.

Electroencephalographic characteristics of emergence from propofol/sufentanil total intravenous anesthesia

We recorded the electroencephalogram (EEG) in 16 patients during propofol/sufentanil total intravenous anesthesia to determine whether EEG changes might predict imminent awakening during emergence. Changes in absolute and relative power in four frequency bands, median frequency (MF), 95th percentile frequency (F95), and two frequency band power ratios (beta/alpha and (alpha+beta)/delta) were quantified. One minute before eye opening, absolute power in the delta and alpha bands had decreased to 49% (25%-73%) and 42% (25%-58%) of the value during the infusion (P > 0.005). MF, F95, and the two frequency band power ratios increased during emergence (P > 0.05). Of the individual spectral variables, only a 50% decrease in absolute alpha power was more than 90% sensitive and specific in predicting eye opening. We conclude that, although pronounced EEG changes occur during emergence from propofol/sufentanil anesthesia, the EEG does not reliably predict eye opening.

[Diprivan: evaluation of the depth of anesthesia]

In daily practice, assessing the exact depth of anaesthesia relies even today on clinical signs such as movements elicited by painful stimuli and/or changes in blood pressure and heart rate. Neurophysiological indicators, such as EEG and evoked potentials, are most probably techniques of the future. They are not yet in routine medical practice, because of the complexity of the information supplied, unresolved technical problems and the high cost of equipment. Nevertheless, these techniques are gradually entering the operating theatre and contribute to the monitoring of the anaesthetized patient. EEG, in particular, regardless of the method of analysis used, seems effective and reliable during the induction phase of anaesthesia, However, the most adequate method of monitoring the maintenance phase or detecting awareness during anaesthesia remains to be produced.